z-logo
open-access-imgOpen Access
Neuroendocrine Merkel Cell Carcinoma Is Associated with Mutations in Key DNA Repair, Epigenetic and Apoptosis Pathways: A Case-Based Study Using Targeted Massively Parallel Sequencing
Author(s) -
Christian Graves,
Ashley Jones,
Justin S. Reynolds,
Jeremy Stuart,
Lucia Pirisi,
Peter Botrous,
James W. Wells
Publication year - 2014
Publication title -
neuroendocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.493
H-Index - 101
eISSN - 1423-0194
pISSN - 0028-3835
DOI - 10.1159/000370310
Subject(s) - biology , cancer research , massive parallel sequencing , merkel cell carcinoma , synaptophysin , dna damage , epigenetics , carcinoma , genetics , dna sequencing , gene , immunology , dna , immunohistochemistry
Merkel cell carcinoma (MCC) is a rare neuroendocrine carcinoma with a poorly understood molecular etiology. We implemented a comprehensive deep sequencing approach to identify mutations in the tumor DNA from a cohort of patients treated at our institution over the past 15 years. Our results indicate mutations that may constitute therapeutic targets in MCC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here